Document:

EXHIBIT 10.11(I)

                                                  September 20, 2006

Mr. Richard Monsorno
8954 Regina Road
Jacksonville, FL 32217

Dear Richard:

Your Employment Agreement, dated as of October 1, 2003, between you and ATC (the
"Agreement") expires on September 30, 2006. The Compensation Committee of the
Board of Directors would like to extend the "Term" as defined in the Agreement
to end on September 30, 2007.

All other terms of your employment as provided in the Agreement shall continue.
As modified by this letter, the Agreement shall remain in full force and effect.

If you are in agreement with the foregoing, please sign the two copies of this
letter in the space provided and return them to me.

Please call me if you have any questions.

                                                  Very truly yours,

                                                  /S/ Kathleen M. Kelly
                                                  ------------------------------
                                                  Kathleen M. Kelly
                                                  Vice President, Administration

KMK

ACCEPTED AND AGREED TO:

/S/ Richard Monsorno
-------------------------
Richard MonsornoOrmat Technologies, Inc.

Director’s Compensation

(As of November 7, 2006)

		
	Fees

	In U.S. Dollars

	Director Retainer

	$25,000

	Board meeting fee

-

In person

-

Joining by telephone to an “in person” meeting

-

Telephonic

	

$2,500

$1,000

$500

	Committee meeting fee

-

In person

-

Telephonic

	

$1,500

$500

	Committee Chair

Audit Committee

	

$7,500

	Expense Reimbursement 

Reimbursement of travel and lodging expenses for Board Meetings

	 

	Options Grants

-

Initial Grant (market price at date of grant; exercisable 12 months from date of grant)

-

Annually from second year (at market price on day of grant)

	

7,500

7,500AMENDMENT
NUMBER ONE
to the
MASTER REPURCHASE AGREEMENT
dated as of
July  12,  2006
by and among
DEUTSCHE BANK AG, NEW
YORK BRANCH,
 successor-in-interest to

DB STRUCTURED
PRODUCTS, INC.,

MORTGAGEIT HOLDINGS,
INC.

and

MORTGAGEIT, INC.

This AMENDMENT
NUMBER ONE (this ‘‘Amendment Number
One’’) is made this 13th day of
November, 2006, by and among Deutsche Bank AG, New York Branch, having
an address at 60 Wall Street, New York, NY 10005, East-Fleet
Finance Limited, having an address at Whiteley Chambers, Don Street,
St. Helier, Jersey JE4 9WG, Channel Islands (each, individually, a
‘‘Buyer’’ and collectively,
‘‘Buyers’’), MortgageIT
Holdings, Inc. and MortgageIT, Inc., each having an address at
33  Maiden Lane, 6th Floor, New York, NY 10038 (each,
individually, a ‘‘Seller’’
and collectively, the
‘‘Sellers’’) to the Master
Repurchase Agreement, dated as of July  12,  2006, by and
among DB Structured Products, Inc., predecessor in interest to the
Buyers (the ‘‘Assignor’’), and the Sellers
(the
‘‘Agreement’’).

RECITALS

        WHEREAS,
the Sellers have requested that the Buyers agree to amend the Agreement
to make the modifications set forth below and the Buyers have agreed to
such request.

        NOW THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which are hereby
acknowledged, and of the mutual covenants herein contained, the parties
hereto hereby agree as follows:

        SECTION
1.    Effective as of November 13, 2006, the Agreement is hereby
amended as follows:

        (a)    Section 2 of the
Agreement is hereby amended by (i) in the definition of
‘‘Jumbo Loan,’’ deleting
‘‘2,000,000’’ and inserting in its place
‘‘3,000,000, provided that any Jumbo Loan with a
principal amount in excess of $2,000,000 may be an Eligible Asset only
if such loan is underwritten in accordance with underwriting guidelines
acceptable to the Buyer in its sole and absolute
discretion’’; and (ii) deleting the definition of
‘‘Maximum Aggregate Purchase Price’’ in its
entirety and replacing it with the
following:

‘‘’Maximum Aggregate Purchase
Price’ means the following amounts for the following time
periods, minus, as of any date of determination on which Purchased
Assets include HELOCs, the undrawn portions, if any, of the Credit
Limits for such HELOCs:

				
	Period:			Maximum
Aggregate
 Purchase Price
	From the Effective
Date to the earlier of January 10, 2007 and the Acceleration Date
(‘‘Period
A’’)			$7,000,000,000
	From
the last day of Period A to the earlier of February  9,
2007 and the 30th day following the Acceleration Date
(‘‘Period
B’’)			$6,000,000,000
	From the
last day of Period B to the earlier of March  9,  2007 and
the 60th day following the Acceleration Date
(‘‘Period
C’’)			$5,000,000,000
	From the
last day of Period C to the earlier of April  11,  2007 and
the 90th day following the Acceleration Date
(‘‘Period
D’’)			$4,000,000,000
	From the
last day of Period D to the earlier of May  11,  2007 and
the 120th day following the Acceleration Date
(‘‘Period
E’’)			$3,000,000,000
	From the
last day of Period E to the earlier of June  11,  2007 and
the 150th day following the Acceleration Date
(‘‘Period
F’’)			$2,000,000,000
	From the
last day of Period F to the earlier of July  11,  2007 and
the 180th day following the Acceleration Date
(‘‘Period
G’’)			$1,000,000,000
	On the
last day of Period G
			                       $0’’
	

        (b)    Exhibit
2 to the Agreement is hereby amended by deleting paragraph (vv) thereof
in its entirety and replacing it with the
following:

(vv)    First Lien Consent.    With
respect to each Loan which is a Closed-End Second Mortgage Loan or
second lien HELOC, either (i) no consent by the holder of the related
first lien is required with respect to such Loan, or (ii) such consent
has been obtained and is contained in the Asset
File.

        SECTION 2.    Defined
Terms.    Any terms capitalized but not otherwise defined herein
shall have the respective meanings set forth in the
Agreement.

        SECTION
3.    Representations.    In order to induce the Buyers to
execute and deliver this Amendment Number One, the Sellers represent to
the Buyers that as of the date hereof, after giving effect to this
Amendment Number One, each Seller is in full compliance with all of the
terms and conditions of the Program Documents and no Default or Event
of Default has occurred under any of the Program
Documents.

        SECTION 4.    Effectiveness of
Amendment.    The effectiveness of this Amendment Number One is
conditioned upon receipt by the Buyers of this Amendment Number One
executed by the Sellers.

        SECTION 5.    Fees and
Expenses.    As a further condition precedent to the
effectiveness of this Amendment Number One, the Sellers shall pay to
the Buyers all reasonable fees and out-of-pocket expenses incurred by
the Buyers in connection with this Amendment Number One (including all
reasonable fees and out of pocket costs and expenses of the
Buyers’ legal counsel incurred in connection with this Amendment
Number One), in accordance with Section 22(a) of the
Agreement.

        SECTION 6.    Limited
Effect.    This Amendment Number One shall become effective upon
the execution hereof by the parties hereto. Except as expressly amended
and modified by this Amendment Number One, the Agreement shall continue
in full force and effect in accordance with its terms. Reference to
this Amendment Number One need not be made in the Agreement or any
other instrument or document executed in connection therewith, or in
any certificate, letter or communication issued or made pursuant to, or
with respect to, the Agreement, any reference in any of such items to
the Agreement being sufficient to refer to the Agreement as amended
hereby.

2

        SECTION 7.    GOVERNING
LAW.    THIS AMENDMENT NUMBER ONE SHALL BE CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK AND THE OBLIGATIONS,
RIGHTS, AND REMEDIES OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN
ACCORDANCE WITH SUCH LAWS WITHOUT REGARD TO CONFLICT OF LAWS DOCTRINE
APPLIED IN SUCH STATE (OTHER THAN SECTION 5-1401 OF THE NEW YORK
GENERAL OBLIGATIONS LAW).

        SECTION
8.    Counterparts.    This Amendment Number One may be
executed by each of the parties hereto on any number of separate
counterparts, each of which shall be an original and all of which taken
together shall constitute one and the same
instrument.

[SIGNATURE PAGE
FOLLOWS]

3

IN WITNESS WHEREOF, the Buyers and the
Sellers have caused this Amendment Number One to be executed and
delivered by their duly authorized officers as of the day and year
first above
written.

				
	DEUTSCHE
BANK AG, NEW YORK BRANCH,
 as Buyer			MORTGAGEIT HOLDINGS,
INC.,
 as Seller
	By:   /s/ Frank
Byrne
Name:   Frank Byrne
Title:    Managing
Director			By: /s/ Glenn J. Mouridy
 Name: Glenn J.
Mouridy
 Title: President and Chief Financial Officer
	By:   /s/ John
McCarthy
Name:   John McCarthy
Title:    Vice
President			 
	EAST-FLEET
FINANCE LIMITED, as Buyer			MORTGAGEIT , INC., as
Seller
	By:   /s/ Peter
Gatehouse
Name:   Peter Gatehouse
Title:    Director			By: /s/ Robert A. Gula
 Name: Robert A. Gula
 Title: Chief
Financial
Officer
	 			 
	

4Exhibit
10.1

On August 1, 2006, Dr. John Womelsdorf commenced his
employment with us as the Company's ‘‘Vice President,
Business Development,’’ at an initial base salary of
$250,000 per annum. The base salary is subject to annual review by the
Compensation and Organizational Development Committee. Dr. Womelsdorf
is also eligible to receive a discretionary annual cash bonus based on
his individual and the Company's performance. The terms of Dr.
Womelsdorf's employment also contain customary provisions with
respect to benefits, reimbursement of expenses and confidentiality. Dr.
Womelsdorf employment is terminable at will upon three months'
notice by either him or the Company.

In addition, on September
1, 2006, Dr. Womelsdorf was granted options to purchase up to 8,334
shares of our Common Stock at an exercise price of $4.65 per share, on
September 30, 2006, he was granted options to purchase up to 8,333
shares of our Common Stock at an exercise price of $4.80 per share; and
on October 31, 2006, he was granted options to purchase up to 8,333
shares of our Common Stock at an exercise price of $5.68 per share, all
pursuant to the terms of the Company's 2006 Stock Option and
Award Plan (the ‘‘Stock Plan’’), which
options vest as follows: one-third of such options vest one year from
each respective date of grant, with 1/24 of the balance of the options
vesting on a monthly basis thereafter. On October 31, 2006, Dr.
Womelsdorf was also granted options to purchase up to 40,000 shares of
our Common Stock, pursuant to the terms of the Stock Plan, at an
exercise price of $5.68 per share. These options vest over a three-year
period, with one-fifth of the options granted vesting on August 1,
2008, 30% of the options granted vesting on August 1, 2009 and
the remaining 50% of the options granted vesting on August 1,
2010.

Dr. Womelsdorf, age 43, was most recently Executive
Director of Licensing and New Business Development in Johnson &
Johnson's Pharmaceuticals Group. Before joining Johnson &
Johnson in April 2002, Dr. Womelsdorf worked as a Global Licensing
Director for F. Hoffmann-La Roche starting on July 1999. While at F.
Hoffmann-La Roche, he closed a variety of transactions in the areas of
Virology, Oncology and Anemia. Prior to working at F. Hoffmann-La
Roche, Dr. Womelsdorf was a Fellow at Baxter International in Business
Development where he worked closely with Research and Development
licensing-in early technologies, which position he held from August
1997. Dr. Womelsdorf was also appointed to the board of directors of
Tibotec Therapeutics in November 2004.

Dr. Womelsdorf earned his
Bachelor of Science in 1988 and his Ph.D. in Physical Chemistry in 1993
from Stevens Institute of Technology. He was also awarded a Masters in
Business Administration from Columbia University in 1997.

Aside
from the terms of Dr. Womelsdorf's employment with the Company,
there is no direct or indirect material interest in any transactions or
any relationships between the Company and its affiliates, on the one
hand, and Dr. Womelsdorf, on the other.

There is no family
relationship between Dr. Womelsdorf and any other Company executive
officer or director.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]